eSpCas9(1.1)_No_FLAG_AAVS1_T2 Citations (7)
Originally described in: A Scalable Genome-Editing-Based Approach for Mapping Multiprotein Complexes in Human Cells.Dalvai M, Loehr J, Jacquet K, Huard CC, Roques C, Herst P, Cote J, Doyon Y Cell Rep. 2015 Oct 7. pii: S2211-1247(15)01020-7. doi: 10.1016/j.celrep.2015.09.009. PubMed Journal
Articles Citing eSpCas9(1.1)_No_FLAG_AAVS1_T2
| Articles |
|---|
| Measurement and Analysis of Lysine Acetylation by KAT Complexes In Vitro and In Vivo. Lashgari A, Lambert JP, Cote J. Methods Mol Biol. 2019;1983:57-77. doi: 10.1007/978-1-4939-9434-2_5. PubMed |
Temporal Expression of Transcription Factor ID2 Improves Natural Killer Cell Differentiation from Human Pluripotent Stem Cells.
Jung J, Chang Y, Jin G, Lian X, Bao X.
ACS Synth Biol. 2022 May 24. doi: 10.1021/acssynbio.2c00017.
PubMed
Associated Plasmids |
| Evaluation of in vitro fibroblast migration by electrospun triple-layered PU-CA/gelatin.PRGF/PU-CA scaffold using an AAVS1 targeted EGFP reporter cell line. Shams F, Moravvej H, Hosseinzadeh S, Kazemi B, Rajabibazl M, Rahimpour A. Bioimpacts. 2022;12(3):219-231. doi: 10.34172/bi.2021.43. Epub 2021 Aug 30. PubMed |
| Identification of HCN1 as a 14-3-3 client. Lankford C, Houtman J, Baker SA. PLoS One. 2022 Jun 9;17(6):e0268335. doi: 10.1371/journal.pone.0268335. eCollection 2022. PubMed |
Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy.
Chang Y, Syahirah R, Wang X, Jin G, Torregrosa-Allen S, Elzey BD, Hummel SN, Wang T, Li C, Lian X, Deng Q, Broxmeyer HE, Bao X.
Cell Rep. 2022 Jul 19;40(3):111128. doi: 10.1016/j.celrep.2022.111128.
PubMed
Associated Plasmids |
| An RNA-immunoprecipitation via CRISPR/dCas13 reveals an interaction between the SARS-CoV-2 5'UTR RNA and the process of human lipid metabolism. Shimizu Y, Bandaru S, Hara M, Young S, Sano T, Usami K, Kurano Y, Lee S, Kumagai-Takei N, Takashiba S, Sano S, Ito T. Sci Rep. 2023 Jun 27;13(1):10413. doi: 10.1038/s41598-023-36680-6. PubMed |
| Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen. Angelo L, Vaillant A, Blanchet M, Labonte P. PLoS One. 2023 Nov 1;18(11):e0293167. doi: 10.1371/journal.pone.0293167. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.